deramciclane has been researched along with 2-hydroxydesipramine in 1 studies
| Studies (deramciclane) | Trials (deramciclane) | Recent Studies (post-2010) (deramciclane) | Studies (2-hydroxydesipramine) | Trials (2-hydroxydesipramine) | Recent Studies (post-2010) (2-hydroxydesipramine) |
|---|---|---|---|---|---|
| 40 | 10 | 2 | 63 | 11 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anttila, M; Björklund, H; De Bruyn, S; Hänninen, J; Laine, K; Rouru, J; Scheinin, H | 1 |
1 trial(s) available for deramciclane and 2-hydroxydesipramine
| Article | Year |
|---|---|
Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Area Under Curve; Camphanes; Cytochrome P-450 CYP2D6; Desipramine; Double-Blind Method; Drug Interactions; Female; Half-Life; Humans; Male; Middle Aged | 2004 |